These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Melanoma and nonmelanoma skin cancer chemoprevention: A role for nicotinamide? Minocha R; Damian DL; Halliday GM Photodermatol Photoimmunol Photomed; 2018 Jan; 34(1):5-12. PubMed ID: 28681504 [TBL] [Abstract][Full Text] [Related]
7. Skin cancer: Nicotinamide reduces new skin cancer risk. Sidaway P Nat Rev Clin Oncol; 2016 Jan; 13(1):4. PubMed ID: 26525684 [No Abstract] [Full Text] [Related]
8. A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention. Chen AC; Martin AJ; Choy B; Fernández-Peñas P; Dalziell RA; McKenzie CA; Scolyer RA; Dhillon HM; Vardy JL; Kricker A; St George G; Chinniah N; Halliday GM; Damian DL N Engl J Med; 2015 Oct; 373(17):1618-26. PubMed ID: 26488693 [TBL] [Abstract][Full Text] [Related]
9. Nicotinamide found to reduce the rate of nonmelanoma skin cancers in high-risk patients. Barton MK CA Cancer J Clin; 2016; 66(2):91-2. PubMed ID: 26754863 [No Abstract] [Full Text] [Related]
10. ACP Journal Club. In high-risk patients, oral nicotinamide reduced number of new nonmelanoma skin cancers during treatment. Hajdenberg J Ann Intern Med; 2016 Feb; 164(4):JC18. PubMed ID: 26882303 [No Abstract] [Full Text] [Related]
11. Nicotinamide: New Indications in Dermatology. Escudero-Góngora MM; Fernández-Peñas P Actas Dermosifiliogr; 2016 Nov; 107(9):777-778. PubMed ID: 27377936 [No Abstract] [Full Text] [Related]
12. Nicotinamide for prevention of nonmelanoma skin cancers: a change in practice? Nestor L; Clowry J; Molloy K; Connolly M; Salim A; Tobin AM Clin Exp Dermatol; 2017 Dec; 42(8):945-946. PubMed ID: 29044731 [No Abstract] [Full Text] [Related]
13. A Reduction in Inflammatory Macrophages May Contribute to Skin Cancer Chemoprevention by Nicotinamide. Minocha R; Martin AJ; Chen AC; Scolyer RA; Lyons JG; McKenzie CA; Madore J; Halliday GM; Damian DL J Invest Dermatol; 2019 Feb; 139(2):467-469. PubMed ID: 30244097 [No Abstract] [Full Text] [Related]
14. A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients. Chen AC; Martin AJ; Dalziell RA; McKenzie CA; Lowe PM; Eris JM; Scolyer RA; Dhillon HM; Vardy JL; Bielski VA; Halliday GM; Damian DL Br J Dermatol; 2016 Nov; 175(5):1073-1075. PubMed ID: 27061568 [No Abstract] [Full Text] [Related]
15. Topical and Systemic Modalities for Chemoprevention of Nonmelanoma Skin Cancer. Nemer KM; Council ML Dermatol Clin; 2019 Jul; 37(3):287-295. PubMed ID: 31084723 [TBL] [Abstract][Full Text] [Related]
16. Prevention of non-melanoma skin cancers with nicotinamide in transplant recipients: a case-control study. Drago F; Ciccarese G; Cogorno L; Calvi C; Marsano LA; Parodi A Eur J Dermatol; 2017 Aug; 27(4):382-385. PubMed ID: 28468736 [TBL] [Abstract][Full Text] [Related]
18. Current Practices for Preventative Interventions for Nonmelanoma Skin Cancers Among Dermatologic Surgeons. Arzeno J; Leavitt E; Lonowski S; Kim J Dermatol Surg; 2021 Jul; 47(7):995-997. PubMed ID: 33587370 [No Abstract] [Full Text] [Related]
19. Nicotinamide: An Update and Review of Safety & Differences from Niacin. Huber R; Wong A Skin Therapy Lett; 2020 Nov; 25(5):7-11. PubMed ID: 33196157 [TBL] [Abstract][Full Text] [Related]
20. Nicotinamide for Skin-Cancer Chemoprevention in Transplantation. Schmults CD; Jambusaria-Pahlajani A; Ruiz E N Engl J Med; 2023 Jun; 388(26):2493. PubMed ID: 37379152 [No Abstract] [Full Text] [Related] [Next] [New Search]